We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
For the 7th year in row the Outsourcing in Clinical Trials Medical Devices Europe Conference gathers a number of pharmaceutical industry experts from all over Europe to engage in collbarative discussion and form new partnerships.
The 2-day programme features key industry trends and the most pressing outsourcing challenges for the European pharma and biotech community.
Please, contact us to arrange a meeting with OCT Clinical team and discuss your trial options.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.